TAKEDA PHARMACEUTICAL CO LTD (TAK)
Clinical trial NCT06405087 updates: 1. completion date: 2032-01-26 → 2030-08-12 2. primary completion date: 2032-01-26 → 2030-08-12
Clinical trial NCT06405087 updates: 1. completion date: 2032-01-26 → 2030-08-12 2. primary completion date: 2032-01-26 → 2030-08-12
Clinical trial NCT02481752: primary purpose: not set → OTHER.
Clinical trial NCT07330258: start date: 2026-06-30 → 2026-06-10.
Clinical trial NCT06902246 updates: 1. status: RECRUITING → WITHDRAWN 2. start date: 2026-05-01 → 2026-08-01 3. completion date: 2031-05-01 → 2031-08-01 4. primary completion date: 2031-05-01 → 2031-08-01 5. enrollment: 30 → 0 participants 6. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05477953: start date: 2026-06-30 → 2026-12-31.
Clinical trial NCT06513312: primary completion date: 2026-05-01 → 2026-05-28.
Clinical trial NCT07613424 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-06-02
Clinical trial NCT05650229: collaborators added: Pharming Technologies B.V..
Clinical trial NCT07578571: start date: 2026-05-01 → 2026-05-21.
Clinical trial NCT03363464 updates: 1. completion date: 2026-05-31 → 2026-06-30 2. primary completion date: 2026-05-31 → 2026-06-30